Kardigan Files for IPO (KARD): MyoKardia Veterans Return
Clinical-stage heart-drug developer Kardigan filed its S-1 for a Nasdaq IPO (ticker: KARD), backed by a JPM/Jefferies/Leerink/TD Cowen syndicate.
biotech ipo 2026
Clinical-stage heart-drug developer Kardigan filed its S-1 for a Nasdaq IPO (ticker: KARD), backed by a JPM/Jefferies/Leerink/TD Cowen syndicate.